Remodeling of Tumor Immune Microenvironment by Oncolytic Viruses
Authors:
- Bin ZhangBZBin Zhang
- Xilei WangXWXilei Wang
- Ping ChengPCPing Cheng
Open Access
- 19 February 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Abstract
Oncolytic viruses (OVs) are potential antitumor agents with unique therapeutic mechanisms. They possess the ability of direct oncolysis and the induction of antitumor immunity. OV can be genetically engineered to potentiate antitumor efficacy by remodeling the tumor immune microenvironment. The present mini review mainly describes the effect of OVs on remodeling of the tumor immune microenvironment and explores the mechanism of regulation of the host immune system and the promotion of the immune cells to destroy carcinoma cells by OVs. Furthermore, this article focuses on the utilization of OVs as vectors for the delivery of immunomodulatory cytokines or antibodies.Keywords
This publication has 85 references indexed in Scilit:
- Antitumoral activity of parvovirus-mediated IL-2 and MCP-3/CCL7 delivery into human pancreatic cancer: implication of leucocyte recruitmentCancer Immunology, Immunotherapy, 2012
- VSV Oncolytic Virotherapy in the B16 Model Depends Upon Intact MyD88 SignalingMolecular Therapy, 2011
- Tumor-Associated Macrophages and Survival in Classic Hodgkin's LymphomaNew England Journal of Medicine, 2010
- Engineered Newcastle Disease Virus as an Improved Oncolytic Agent Against Hepatocellular CarcinomaMolecular Therapy, 2010
- Attraction and Activation of Dendritic Cells at the Site of Tumor Elicits Potent Antitumor ImmunityMolecular Therapy, 2009
- G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse modelsProceedings of the National Academy of Sciences, 2009
- Cytokine-induced memory-like natural killer cellsProceedings of the National Academy of Sciences, 2009
- PD-1 Ligand Expression by Human Colonic Myofibroblasts/Fibroblasts Regulates CD4+ T-Cell ActivityGastroenterology, 2008
- Cross-Priming of Cytotoxic T Cells Dictates Antigen Requisites for Modified Vaccinia Virus Ankara Vector VaccinesJournal of Virology, 2007
- The highly attenuated vaccinia virus strain modified virus Ankara induces apoptosis in melanoma cells and allows bystander dendritic cells to generate a potent anti-tumoral immunityClinical and Experimental Immunology, 2006